OUR PRESCRIBING PHILOSOPHY
GLP-1 and hormone replacement therapy — within a structured care plan
If you are researching GLP-1 medication, hormone replacement therapy, or both — you do not need to arrive knowing which is right for you. What matters is that you are looking for a provider who prescribes with clinical rigor, not convenience.
One provider. One clinical relationship. Every medication managed within the full context of your metabolic and hormonal health.
HOW WE PRESCRIBE
Thorough evaluation before intervention
Every medication we prescribe follows the same logic: thorough evaluation before intervention.
Medication is never a standalone solution; it is one component of a structured plan. The Metabolic Evaluation identifies your specific metabolic and hormonal patterns, and the timing of every intervention follows from there.
GLP-1
Ongoing care or a planned taper
Individualized timing governed by your evaluation
GLP-1 enters your plan when and how your Metabolic Evaluation results indicate — for some patients early, for others after the metabolic foundation is established. What never changes: it is prescribed on evaluation, not on request, and it arrives alongside the nutrition and strength structure to minimize any loss of lean mass.
Rigorous monitoring
Your response is tracked and your dosing adjusted using both objective and subjective data — body composition data, side effects, and your daily experience of the medication. Dosing follows your trends, not a standard titration schedule. This is where the difference between a structured care plan and a prescription mill becomes visible.
Shared decision-making
Obesity is a chronic, relapsing disease, and GLP-1 is a durable, long-term option for managing it — continued as long as it remains clinically appropriate. For some patients the right path is a planned, monitored taper once the metabolic foundation holds; for others, ongoing management is the clinically sound choice. This is a decision made with you, not for you.
HORMONE REPLACEMENT THERAPY
Ongoing care
Individualized timing governed by your evaluation
Your metabolic and hormonal health are assessed together from day one. If hormonal disruption is driving your metabolic instability, HRT enters the plan early. If hormonal symptoms are downstream of insulin resistance, the metabolic foundation comes first. The Metabolic Evaluation tells us which sequence is right for you.
Rigorous monitoring
HRT is not a once-a-year prescription written and forgotten. Labs are reassessed on a defined monitoring schedule, your response is reviewed at every visit, and your care is adjusted as your hormonal status evolves through perimenopause, menopause, and beyond. It is durable, ongoing care — managed inside the same clinical relationship as your metabolic health.
Shared decision-making
We prescribe both conventional and compounded forms of HRT, including bioidentical formulations. Because hormonal response is highly individual, the right form — and its delivery — is a clinical decision made with each patient, individualized by your provider based on your labs, your symptoms, and your clinical picture. There is no one-size-fits-all house default.
WHERE MEDICATION MANAGEMENT BEGINS
The starting point is the same for GLP-1 as it is for HRT
The Metabolic Evaluation maps your full picture, identifies your pattern, and is where every prescribing decision begins. We do not prescribe outside of an active clinical partnership.